Rangeley Capital, LLC Hille Vax, Inc. Transaction History
Rangeley Capital, LLC
- $83.8 Billion
- Q2 2025
A detailed history of Rangeley Capital, LLC transactions in Hille Vax, Inc. stock. As of the latest transaction made, Rangeley Capital, LLC holds 153,790 shares of HLVX stock, worth $319,883. This represents 0.37% of its overall portfolio holdings.
Number of Shares
153,790Holding current value
$319,883% of portfolio
0.37%Shares
1 transactions
Others Institutions Holding HLVX
# of Institutions
74Shares Held
36.1MCall Options Held
0Put Options Held
0-
Frazier Life Sciences Management, L.P. Menlo Park, CA10.6MShares$22.1 Million1.11% of portfolio
-
Tang Capital Management LLC San Diego, CA4.92MShares$10.2 Million0.59% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA2.42MShares$5.03 Million0.41% of portfolio
-
Black Rock Inc. New York, NY2.09MShares$4.35 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA1.95MShares$4.06 Million0.0% of portfolio
About HilleVax, Inc.
- Ticker HLVX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 33,427,200
- Market Cap $69.5M
- Description
- HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.